Global Long-acting Reversible Contraceptives (LARCs) Market Research Report 2023

Report ID: 1717575 | Published Date: Jan 2025 | No. of Page: 101 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Long-acting Reversible Contraceptives (LARCs) Market Overview
    1.1 Product Overview and Scope of Long-acting Reversible Contraceptives (LARCs)
    1.2 Long-acting Reversible Contraceptives (LARCs) Segment by Type
        1.2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate Comparison by Type (2022-2028)
        1.2.2 Hormonal Intrauterine Devices
        1.2.3 Copper Intrauterine Devices
        1.2.4 Contraceptive Implants
        1.2.5 Others
    1.3 Long-acting Reversible Contraceptives (LARCs) Segment by Application
        1.3.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Comparison by Application: (2022-2028)
        1.3.2 Age 20-24
        1.3.3 Age 25-34
        1.3.4 Age 35-44
        1.3.5 Others
    1.4 Global Long-acting Reversible Contraceptives (LARCs) Market Size Estimates and Forecasts
        1.4.1 Global Long-acting Reversible Contraceptives (LARCs) Revenue 2017-2028
        1.4.2 Global Long-acting Reversible Contraceptives (LARCs) Sales 2017-2028
        1.4.3 Long-acting Reversible Contraceptives (LARCs) Market Size by Region: 2017 Versus 2021 Versus 2028
2 Long-acting Reversible Contraceptives (LARCs) Market Competition by Manufacturers
    2.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2017-2022)
    2.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Manufacturers (2017-2022)
    2.3 Global Long-acting Reversible Contraceptives (LARCs) Average Price by Manufacturers (2017-2022)
    2.4 Manufacturers Long-acting Reversible Contraceptives (LARCs) Manufacturing Sites, Area Served, Product Type
    2.5 Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation and Trends
        2.5.1 Long-acting Reversible Contraceptives (LARCs) Market Concentration Rate
        2.5.2 The Global Top 5 and Top 10 Largest Long-acting Reversible Contraceptives (LARCs) Players Market Share by Revenue
        2.5.3 Global Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Long-acting Reversible Contraceptives (LARCs) Retrospective Market Scenario by Region
    3.1 Global Long-acting Reversible Contraceptives (LARCs) Retrospective Market Scenario in Sales by Region: 2017-2022
    3.2 Global Long-acting Reversible Contraceptives (LARCs) Retrospective Market Scenario in Revenue by Region: 2017-2022
    3.3 North America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
        3.3.1 North America Long-acting Reversible Contraceptives (LARCs) Sales by Country
        3.3.2 North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country
        3.3.3 United States
        3.3.4 Canada
    3.4 Europe Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
        3.4.1 Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country
        3.4.2 Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country
        3.4.3 Germany
        3.4.4 France
        3.4.5 U.K.
        3.4.6 Italy
        3.4.7 Russia
    3.5 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Region
        3.5.1 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region
        3.5.2 Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region
        3.5.3 China
        3.5.4 Japan
        3.5.5 South Korea
        3.5.6 India
        3.5.7 Australia
        3.5.8 China Taiwan
        3.5.9 Indonesia
        3.5.10 Thailand
        3.5.11 Malaysia
    3.6 Latin America Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
        3.6.1 Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country
        3.6.2 Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country
        3.6.3 Mexico
        3.6.4 Brazil
        3.6.5 Argentina
    3.7 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Market Facts & Figures by Country
        3.7.1 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country
        3.7.2 Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country
        3.7.3 Turkey
        3.7.4 Saudi Arabia
        3.7.5 UAE
4 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Analysis by Type
    4.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)
    4.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Type (2017-2022)
    4.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2022)
5 Global Long-acting Reversible Contraceptives (LARCs) Historic Market Analysis by Application
    5.1 Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)
    5.2 Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Application (2017-2022)
    5.3 Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2022)
6 Key Companies Profiled
    6.1 Bayer
        6.1.1 Bayer Corporation Information
        6.1.2 Bayer Description and Business Overview
        6.1.3 Bayer Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.1.4 Bayer Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.1.5 Bayer Recent Developments/Updates
    6.2 Merck
        6.2.1 Merck Corporation Information
        6.2.2 Merck Description and Business Overview
        6.2.3 Merck Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.2.4 Merck Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.2.5 Merck Recent Developments/Updates
    6.3 Cooper Companies
        6.3.1 Cooper Companies Corporation Information
        6.3.2 Cooper Companies Description and Business Overview
        6.3.3 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.3.4 Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.3.5 Cooper Companies Recent Developments/Updates
    6.4 AbbVie Allergan
        6.4.1 AbbVie Allergan Corporation Information
        6.4.2 AbbVie Allergan Description and Business Overview
        6.4.3 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.4.5 AbbVie Allergan Recent Developments/Updates
    6.5 Yantai JiShengYaoXie
        6.5.1 Yantai JiShengYaoXie Corporation Information
        6.5.2 Yantai JiShengYaoXie Description and Business Overview
        6.5.3 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.5.4 Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.5.5 Yantai JiShengYaoXie Recent Developments/Updates
    6.6 H & J Medical
        6.6.1 H & J Medical Corporation Information
        6.6.2 H & J Medical Description and Business Overview
        6.6.3 H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.6.4 H & J Medical Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.6.5 H & J Medical Recent Developments/Updates
    6.7 HRA Pharma
        6.6.1 HRA Pharma Corporation Information
        6.6.2 HRA Pharma Description and Business Overview
        6.6.3 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.4.4 HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.7.5 HRA Pharma Recent Developments/Updates
    6.8 Pregna
        6.8.1 Pregna Corporation Information
        6.8.2 Pregna Description and Business Overview
        6.8.3 Pregna Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.8.4 Pregna Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.8.5 Pregna Recent Developments/Updates
    6.9 ASPIVIX
        6.9.1 ASPIVIX Corporation Information
        6.9.2 ASPIVIX Description and Business Overview
        6.9.3 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.9.4 ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.9.5 ASPIVIX Recent Developments/Updates
    6.10 Shanghai Dahua Pharmaceuticals
        6.10.1 Shanghai Dahua Pharmaceuticals Corporation Information
        6.10.2 Shanghai Dahua Pharmaceuticals Description and Business Overview
        6.10.3 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.10.4 Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.10.5 Shanghai Dahua Pharmaceuticals Recent Developments/Updates
    6.11 Williams Medical Supplies
        6.11.1 Williams Medical Supplies Corporation Information
        6.11.2 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.11.3 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.11.4 Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.11.5 Williams Medical Supplies Recent Developments/Updates
    6.12 Laboratoire 7 MED
        6.12.1 Laboratoire 7 MED Corporation Information
        6.12.2 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.12.3 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.12.4 Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.12.5 Laboratoire 7 MED Recent Developments/Updates
    6.13 Durbin
        6.13.1 Durbin Corporation Information
        6.13.2 Durbin Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.13.3 Durbin Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.13.4 Durbin Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.13.5 Durbin Recent Developments/Updates
    6.14 Laboratoire CCD
        6.14.1 Laboratoire CCD Corporation Information
        6.14.2 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.14.3 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.14.4 Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.14.5 Laboratoire CCD Recent Developments/Updates
    6.15 Prosan
        6.15.1 Prosan Corporation Information
        6.15.2 Prosan Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.15.3 Prosan Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.15.4 Prosan Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.15.5 Prosan Recent Developments/Updates
    6.16 OCON
        6.16.1 OCON Corporation Information
        6.16.2 OCON Long-acting Reversible Contraceptives (LARCs) Description and Business Overview
        6.16.3 OCON Long-acting Reversible Contraceptives (LARCs) Sales, Revenue and Gross Margin (2017-2022)
        6.16.4 OCON Long-acting Reversible Contraceptives (LARCs) Product Portfolio
        6.16.5 OCON Recent Developments/Updates
7 Long-acting Reversible Contraceptives (LARCs) Manufacturing Cost Analysis
    7.1 Long-acting Reversible Contraceptives (LARCs) Key Raw Materials Analysis
       7.1.1 Key Raw Materials
       7.1.2 Key Suppliers of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
    7.3 Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
    7.4 Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
    8.1 Marketing Channel
    8.2 Long-acting Reversible Contraceptives (LARCs) Distributors List
    8.3 Long-acting Reversible Contraceptives (LARCs) Customers
9 Long-acting Reversible Contraceptives (LARCs) Market Dynamics
    9.1 Long-acting Reversible Contraceptives (LARCs) Industry Trends
    9.2 Long-acting Reversible Contraceptives (LARCs) Market Drivers
    9.3 Long-acting Reversible Contraceptives (LARCs) Market Challenges
    9.4 Long-acting Reversible Contraceptives (LARCs) Market Restraints
10 Global Market Forecast
    10.1 Long-acting Reversible Contraceptives (LARCs) Market Estimates and Projections by Type
        10.1.1 Global Forecasted Sales of Long-acting Reversible Contraceptives (LARCs) by Type (2023-2028)
        10.1.2 Global Forecasted Revenue of Long-acting Reversible Contraceptives (LARCs) by Type (2023-2028)
    10.2 Long-acting Reversible Contraceptives (LARCs) Market Estimates and Projections by Application
        10.2.1 Global Forecasted Sales of Long-acting Reversible Contraceptives (LARCs) by Application (2023-2028)
        10.2.2 Global Forecasted Revenue of Long-acting Reversible Contraceptives (LARCs) by Application (2023-2028)
    10.3 Long-acting Reversible Contraceptives (LARCs) Market Estimates and Projections by Region
        10.3.1 Global Forecasted Sales of Long-acting Reversible Contraceptives (LARCs) by Region (2023-2028)
        10.3.2 Global Forecasted Revenue of Long-acting Reversible Contraceptives (LARCs) by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
    12.1 Methodology/Research Approach
        12.1.1 Research Programs/Design
        12.1.2 Market Size Estimation
        12.1.3 Market Breakdown and Data Triangulation
    12.2 Data Source
        12.2.1 Secondary Sources
        12.2.2 Primary Sources
    12.3 Author List
    12.4 Disclaimer

List of Tables
    Table 1. Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
    Table 2. Global Long-acting Reversible Contraceptives (LARCs) Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
    Table 3. Global Long-acting Reversible Contraceptives (LARCs) Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
    Table 4. Global Long-acting Reversible Contraceptives (LARCs) Market Competitive Situation by Manufacturers in 2021
    Table 5. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) of Key Manufacturers (2017-2022)
    Table 6. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Manufacturers (2017-2022)
    Table 7. Global Long-acting Reversible Contraceptives (LARCs) Revenue (US$ Million) by Manufacturers (2017-2022)
    Table 8. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers (2017-2022)
    Table 9. Global Market Long-acting Reversible Contraceptives (LARCs) Average Price (US$/Unit) of Key Manufacturers (2017-2022)
    Table 10. Manufacturers Long-acting Reversible Contraceptives (LARCs) Manufacturing Sites and Area Served
    Table 11. Manufacturers Long-acting Reversible Contraceptives (LARCs) Product Type
    Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 13. Global Long-acting Reversible Contraceptives (LARCs) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long-acting Reversible Contraceptives (LARCs) as of 2021)
    Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 15. Global Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
    Table 16. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)
    Table 17. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (US$ Million)
    Table 18. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2022)
    Table 19. North America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 20. North America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)
    Table 21. North America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
    Table 22. North America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)
    Table 23. Europe Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 24. Europe Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)
    Table 25. Europe Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
    Table 26. Europe Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)
    Table 27. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales by Region (2017-2022) & (K Units)
    Table 28. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)
    Table 29. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue by Region (2017-2022) & (US$ Million)
    Table 30. Asia Pacific Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2022)
    Table 31. Latin America Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 32. Latin America Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)
    Table 33. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
    Table 34. Latin America Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)
    Table 35. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales by Country (2017-2022) & (K Units)
    Table 36. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Country (2017-2022)
    Table 37. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue by Country (2017-2022) & (US$ Million)
    Table 38. Middle East and Africa Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Country (2017-2022)
    Table 39. Global Long-acting Reversible Contraceptives (LARCs) Sales by Type (2017-2022) & (K Units)
    Table 40. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Type (2017-2022)
    Table 41. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Type (2017-2022) & (US$ Million)
    Table 42. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Type (2017-2022)
    Table 43. Global Long-acting Reversible Contraceptives (LARCs) Price by Type (2017-2022) & (US$/Unit)
    Table 44. Global Long-acting Reversible Contraceptives (LARCs) Sales (K Units) by Application (2017-2022)
    Table 45. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Application (2017-2022)
    Table 46. Global Long-acting Reversible Contraceptives (LARCs) Revenue by Application (2017-2022) & (US$ Million)
    Table 47. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Application (2017-2022)
    Table 48. Global Long-acting Reversible Contraceptives (LARCs) Price by Application (2017-2022) & (US$/Unit)
    Table 49. Bayer Corporation Information
    Table 50. Bayer Description and Business Overview
    Table 51. Bayer Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 52. Bayer Long-acting Reversible Contraceptives (LARCs) Product
    Table 53. Bayer Recent Developments/Updates
    Table 54. Merck Corporation Information
    Table 55. Merck Description and Business Overview
    Table 56. Merck Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 57. Merck Long-acting Reversible Contraceptives (LARCs) Product
    Table 58. Merck Recent Developments/Updates
    Table 59. Cooper Companies Corporation Information
    Table 60. Cooper Companies Description and Business Overview
    Table 61. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 62. Cooper Companies Long-acting Reversible Contraceptives (LARCs) Product
    Table 63. Cooper Companies Recent Developments/Updates
    Table 64. AbbVie Allergan Corporation Information
    Table 65. AbbVie Allergan Description and Business Overview
    Table 66. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 67. AbbVie Allergan Long-acting Reversible Contraceptives (LARCs) Product
    Table 68. AbbVie Allergan Recent Developments/Updates
    Table 69. Yantai JiShengYaoXie Corporation Information
    Table 70. Yantai JiShengYaoXie Description and Business Overview
    Table 71. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 72. Yantai JiShengYaoXie Long-acting Reversible Contraceptives (LARCs) Product
    Table 73. Yantai JiShengYaoXie Recent Developments/Updates
    Table 74. H & J Medical Corporation Information
    Table 75. H & J Medical Description and Business Overview
    Table 76. H & J Medical Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 77. H & J Medical Long-acting Reversible Contraceptives (LARCs) Product
    Table 78. H & J Medical Recent Developments/Updates
    Table 79. HRA Pharma Corporation Information
    Table 80. HRA Pharma Description and Business Overview
    Table 81. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 82. HRA Pharma Long-acting Reversible Contraceptives (LARCs) Product
    Table 83. HRA Pharma Recent Developments/Updates
    Table 84. Pregna Corporation Information
    Table 85. Pregna Description and Business Overview
    Table 86. Pregna Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 87. Pregna Long-acting Reversible Contraceptives (LARCs) Product
    Table 88. Pregna Recent Developments/Updates
    Table 89. ASPIVIX Corporation Information
    Table 90. ASPIVIX Description and Business Overview
    Table 91. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 92. ASPIVIX Long-acting Reversible Contraceptives (LARCs) Product
    Table 93. ASPIVIX Recent Developments/Updates
    Table 94. Shanghai Dahua Pharmaceuticals Corporation Information
    Table 95. Shanghai Dahua Pharmaceuticals Description and Business Overview
    Table 96. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 97. Shanghai Dahua Pharmaceuticals Long-acting Reversible Contraceptives (LARCs) Product
    Table 98. Shanghai Dahua Pharmaceuticals Recent Developments/Updates
    Table 99. Williams Medical Supplies Corporation Information
    Table 100. Williams Medical Supplies Description and Business Overview
    Table 101. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 102. Williams Medical Supplies Long-acting Reversible Contraceptives (LARCs) Product
    Table 103. Williams Medical Supplies Recent Developments/Updates
    Table 104. Laboratoire 7 MED Corporation Information
    Table 105. Laboratoire 7 MED Description and Business Overview
    Table 106. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 107. Laboratoire 7 MED Long-acting Reversible Contraceptives (LARCs) Product
    Table 108. Laboratoire 7 MED Recent Developments/Updates
    Table 109. Durbin Corporation Information
    Table 110. Durbin Description and Business Overview
    Table 111. Durbin Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 112. Durbin Long-acting Reversible Contraceptives (LARCs) Product
    Table 113. Durbin Recent Developments/Updates
    Table 114. Laboratoire CCD Corporation Information
    Table 115. Laboratoire CCD Description and Business Overview
    Table 116. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 117. Laboratoire CCD Long-acting Reversible Contraceptives (LARCs) Product
    Table 118. Laboratoire CCD Recent Developments/Updates
    Table 119. Prosan Corporation Information
    Table 120. Prosan Description and Business Overview
    Table 121. Prosan Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 122. Prosan Long-acting Reversible Contraceptives (LARCs) Product
    Table 123. Prosan Recent Developments/Updates
    Table 124. OCON Corporation Information
    Table 125. OCON Description and Business Overview
    Table 126. OCON Long-acting Reversible Contraceptives (LARCs) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
    Table 127. OCON Long-acting Reversible Contraceptives (LARCs) Product
    Table 128. OCON Recent Developments/Updates
    Table 129. Production Base and Market Concentration Rate of Raw Material
    Table 130. Key Suppliers of Raw Materials
    Table 131. Long-acting Reversible Contraceptives (LARCs) Distributors List
    Table 132. Long-acting Reversible Contraceptives (LARCs) Customers List
    Table 133. Long-acting Reversible Contraceptives (LARCs) Market Trends
    Table 134. Long-acting Reversible Contraceptives (LARCs) Market Drivers
    Table 135. Long-acting Reversible Contraceptives (LARCs) Market Challenges
    Table 136. Long-acting Reversible Contraceptives (LARCs) Market Restraints
    Table 137. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Type (2023-2028) & (K Units)
    Table 138. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Type (2023-2028)
    Table 139. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 140. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Type (2023-2028)
    Table 141. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Application (2023-2028) & (K Units)
    Table 142. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Application (2023-2028)
    Table 143. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 144. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Application (2023-2028)
    Table 145. Global Long-acting Reversible Contraceptives (LARCs) Sales Forecast by Region (2023-2028) & (K Units)
    Table 146. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share Forecast by Region (2023-2028)
    Table 147. Global Long-acting Reversible Contraceptives (LARCs) Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 148. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share Forecast by Region (2023-2028)
    Table 149. Research Programs/Design for This Report
    Table 150. Key Data Information from Secondary Sources
    Table 151. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Long-acting Reversible Contraceptives (LARCs)
    Figure 2. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Type in 2021 & 2028
    Figure 3. Hormonal Intrauterine Devices Product Picture
    Figure 4. Copper Intrauterine Devices Product Picture
    Figure 5. Contraceptive Implants Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Long-acting Reversible Contraceptives (LARCs) Market Share by Application in 2021 & 2028
    Figure 8. Age 20-24
    Figure 9. Age 25-34
    Figure 10. Age 35-44
    Figure 11. Others
    Figure 12. Global Long-acting Reversible Contraceptives (LARCs) Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Long-acting Reversible Contraceptives (LARCs) Market Size (2017-2028) & (US$ Million)
    Figure 14. Global Long-acting Reversible Contraceptives (LARCs) Sales (2017-2028) & (K Units)
    Figure 15. Long-acting Reversible Contraceptives (LARCs) Sales Share by Manufacturers in 2021
    Figure 16. Global Long-acting Reversible Contraceptives (LARCs) Revenue Share by Manufacturers in 2021
    Figure 17. The Global 5 and 10 Largest Long-acting Reversible Contraceptives (LARCs) Players: Market Share by Revenue in 2021
    Figure 18. Long-acting Reversible Contraceptives (LARCs) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 19. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region (2017-2022)
    Figure 20. Global Long-acting Reversible Contraceptives (LARCs) Sales Market Share by Region in 2021
    Figure 21. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region (2017-2022)
    Figure 22. Global Long-acting Reversible Contraceptives (LARCs) Revenue Market Share by Region in 2021
    Figure 23. United States Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 24. Canada Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 25. Germany Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 26. France Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 27. U.K. Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 28. Italy Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 29. Russia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 30. China Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 31. Japan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 32. South Korea Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 33. India Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 34. Australia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 35. China Taiwan Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 36. Indonesia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 37. Thailand Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 38. Malaysia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 39. Mexico Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 40. Brazil Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 41. Argentina Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 42. Turkey Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 43. Saudi Arabia Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 44. UAE Long-acting Reversible Contraceptives (LARCs) Revenue Growth Rate (2017-2022) & (US$ Million)
    Figure 45. Sales Market Share of Long-acting Reversible Contraceptives (LARCs) by Type (2017-2022)
    Figure 46. Manufacturing Cost Structure of Long-acting Reversible Contraceptives (LARCs)
    Figure 47. Manufacturing Process Analysis of Long-acting Reversible Contraceptives (LARCs)
    Figure 48. Long-acting Reversible Contraceptives (LARCs) Industrial Chain Analysis
    Figure 49. Channels of Distribution
    Figure 50. Distributors Profiles
    Figure 51. Bottom-up and Top-down Approaches for This Report
    Figure 52. Data Triangulation
    Figure 53. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bayer
Merck
Cooper Companies
AbbVie Allergan
Yantai JiShengYaoXie
H & J Medical
HRA Pharma
Pregna
ASPIVIX
Shanghai Dahua Pharmaceuticals
Williams Medical Supplies
Laboratoire 7 MED
Durbin
Laboratoire CCD
Prosan
OCON
Frequently Asked Questions
Long-acting Reversible Contraceptives (LARCs) report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Long-acting Reversible Contraceptives (LARCs) report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Long-acting Reversible Contraceptives (LARCs) report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tubal Rings

The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More